Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07457060) titled 'Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine' on March 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Sinovac Biotech Co., Ltd
Condition:
Poliomyelitis
Intervention:
Biological: 2wIPV+1sIPV
Biological: 1wIPV+2sIPV
Biological: 3wIPV
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: November 27, 2025
Target Sample Size: 480
Countries of Recruitment:
Philippines
To know more, visit...